Page last updated: 2024-09-03

n-methylisoindigotin and Diabetes Mellitus, Type 2

n-methylisoindigotin has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Li, J; Liu, JJ; Ma, N; Mu, YL; Shentu, LM; Sun, Y; Wang, LY; Wang, Y; Zhang, GM	1

Other Studies

1 other study(ies) available for n-methylisoindigotin and Diabetes Mellitus, Type 2

Article	Year
Inhibition of NF-κB and Wnt/β-catenin/GSK3β Signaling Pathways Ameliorates Cardiomyocyte Hypertrophy and Fibrosis in Streptozotocin (STZ)-induced Type 1 Diabetic Rats. Current medical science, 2020, Volume: 40, Issue:1 Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Lipid Metabolism; Male; Myocytes, Cardiac; NF-kappa B; Pyrrolidines; Rats; Streptozocin; Thiocarbamates; Wnt Signaling Pathway	2020

Article

Year

Inhibition of NF-κB and Wnt/β-catenin/GSK3β Signaling Pathways Ameliorates Cardiomyocyte Hypertrophy and Fibrosis in Streptozotocin (STZ)-induced Type 1 Diabetic Rats.

Current medical science, 2020, Volume: 40, Issue:1

Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Lipid Metabolism; Male; Myocytes, Cardiac; NF-kappa B; Pyrrolidines; Rats; Streptozocin; Thiocarbamates; Wnt Signaling Pathway

2020